Vitamin A and fish oils for retinitis pigmentosa

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 12, 2013, Pages

  Rayapudi, Sobharani ^a   Schwartz, Stephen G ^b   Wang, Xue ^a   Chavis, Pamela ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; RETINOL; FISH OIL; VITAMIN;

ADVERSE EVENT; ANATOMICAL VARIATION; CLINICAL OUTCOME; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DATA EXTRACTION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; ELECTRORETINOGRAM; FOLLOW UP; GENETIC PREDISPOSITION; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINITIS PIGMENTOSA; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; VISUAL ACUITY; VISUAL FIELD; VITAMIN SUPPLEMENTATION; ELECTRORETINOGRAPHY;

DOCOSAHEXAENOIC ACIDS; ELECTRORETINOGRAPHY; FISH OILS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINITIS PIGMENTOSA; VISUAL ACUITY; VITAMIN A; VITAMINS;

EID: 84897368229     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008428.pub2     Document Type: Review

References (35)

1. Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, et al.A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Archives of Ophthalmology 1993;111(6):761-72.
2. Berson EL, Rosner B, Sandberg MA, Hayes KC, Weigel-DiFranco C, Moser A, et al.Clinical trial of Docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Archives of Ophthalmology 2004;122(9):1297-1305.
3. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al.Further evaluation of docosahexaenoic acid inpatients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Archives of Ophthalmology 2004;122(9):1306-14.
4. Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. American Journal of Ophthalmology 2004;137(4):704-18.
5. Bergsma DR, Wolf ML. A therapeutic trial of vitamin A in patients with pigmentary retinal degenerations: a negative study. Advances in Experimental Medicine and Biology 1977;77:197-209.
6. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, et al.Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Archives of Ophthalmology 2010;128(4):403-11.
7. Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 2000;71(3):147-64.
8. Fex GA, Andréasson S, Ehinger B. Serum retinoids in retinitis pigmentosa patients treated with vitamin A. Graefe's Archive for Clinical and Experimental Ophthalmology 1996;234(Suppl 1):S18-21.
9. Sibulesky L, Hayes KC, Pronczuk A, Weigel-DiFranco C, Rosner B, Berson EL. Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa. American Journal of Clinical Nutrition 1999;69(4):656-63.
10. Tcherkes LA, Averbach IM, Iakovleva SP. Use of vitamin A in retinitis pigmentosa. Vjestnik Oftalmologyi 1950;29(1):33-40.
11. Wheaton DH, Hoffman DR, Locke KG, Watkins RB, Birch DG. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Archives of Ophthalmology 2003;121(9):1269-78.
12. Anderson DR, Feuer WJ, Alward WL, Skuta GL. Threshold equivalence between perimeters. American Journal of Ophthalmology 1989;107(5):493-505.
13. Berson EL, Gouras P, Hoff M. Temporal aspects of the electroretinogram. Archives of Ophthalmology 1969;81(2):207-14.
14. Besron EL. Nutrition and retinal degenerations: Vitamin A, taurine, ornithine, and phytanic acid. Retina 1982;2(4):236-55.
15. Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH. Natural course of retinitis pigmentosa over a three-year interval. American Journal of Ophthalmology 1985;99(3):240-51.
16. Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al.Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Archives of Ophthalmology 2004;122(9):1306-14.
17. Birch DG. A randomized placebo-controlled clinical trial of docosahexaenoic acid (DHA) supplementation for X-linked retinitis pigmentosa. Retina 2005;25(Suppl 8):S52-4.
18. Borly L, Wille-Jorgensen P, Rasmussen MS, Andersen BR. Problems with retrieving original data: is it a selection bias?. 9th Annual Cochrane Colloquium; 2001 Oct 9-13; Lyon, France. 2001.
19. Chen Y, Houghton LA, Brenna JT, Noy N. Docosahexaenoic acid modulates the interactions of the interphotoreceptor retinoid-binding protein with 11-cis-retinal. Journal of Biological Chemistry 1996;271(34):20507-15.
20. Daiger SP, Bowne SJ, Sullivan LS. Perspective on genes and mutations causing retinitis pigmentosa. Archives of Ophthalmology 2007;125(2):151-8.
21. Dowling JE, Wald G. The biological function of vitamin A acid. Proceedings of the National Academy of Sciences 1960;46(5):587-608.
22. Flynn MF, Fishman GA, Anderson RJ, Roberts DK. Retrospective longitudinal study of visual acuity change in patients with retinitis pigmentosa. Retina 2001;21(6):639-46.
23. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
24. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368(9549):1795-809.
25. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
26. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
27. Hodge W, Barnes D, Schachter HM, Pan Y, Lowcock EC, Zhang L, et al.Effects of omega-3 fatty acids on eye health. Evidence Report:Technology Assessment (Summary) 2005;117:1-6.
28. Holopigian K, Greenstein V, Seiple W, Carr RE. Rates of change differ among measures of visual function in patients with retinitis pigmentosa. Ophthalmology 1996;103(3):398-405.
29. Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?. Archives of Ophthalmology 2010;128(4):493-5.
30. Norton EW. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Archives of Ophthalmology 1993;111(11):1460.
31. Oishi A, Nakamura H, Tatsumi I, Sasahara M, Kojima H, Kurimoto M, et al.Optical coherence tomographic pattern and focal electroretinogram in patients with retinitis pigmentosa. Eye 2009;23(2):299-303.
32. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
33. Walia S, Fishman GA, Edward DP, Lindemann M. Retinal nerve fiber layer defects in RP patients. Investigative Ophthalmology and Visual Science 2007;48(10):4748-52.
34. Witkin AJ, Ko TH, Fujimoto JG, Chan A, Drexler W, Schuman JS, et al.Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases. American Journal of Ophthalmology 2006;142(6):945-52.
35. Rayapudi S, Schwartz SG, Chavis P. Vitamin A and fish oils for retinitis pigmentosa. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD008428]